Advertisement

Topics

NxStage Medical Sells to Dialysis Giant Fresenius for $2B

08:45 EDT 7 Aug 2017 | Xconomy

German dialysis giant Fresenius is paying $2 billion to acquire NxStage Medical, a Lawrence, MA-based developer of products for patients dealing with kidney failure. Fresenius is paying $30 a share for NxStage (NASDAQ: NXTM), a roughly 28 percent premium to the company’s $23.14 closing price on Friday. That price represents an all-time high for NxStage: […]

Original Article: NxStage Medical Sells to Dialysis Giant Fresenius for $2B

NEXT ARTICLE

More From BioPortfolio on "NxStage Medical Sells to Dialysis Giant Fresenius for $2B"

Quick Search
Advertisement
 

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...